Special Report: PBS now a completely different story
Last week's Budget may have revealed a $2.6 billion downward revision in PBS spending forecasts but it is the changed relationship between PBS spending and GDP that shows a tired 'sustainability' story no longer applies » more
Australia joins US Actos suit - Lawyers call on patients to come
forward and register in group action by June 7; Vioxx case not over for
Merck - Judge refuses to approve $540,000 settlement around Vioxx;
Diane benefits outweigh risks, EMA - Regulator says benefits of
Bayer's acne drug outweigh blood clot risk
The number of new medicines listed on the PBS in 2011-12 was the lowest for 20 years and reform savings out to 2018 will total $18 billion says a report released today from the Centre for Strategic Economic Studies
Worries that the PBS is unsustainable because it will eat up too much of gross
domestic product have been kiboshed by the Medicines Partnership of Australia's
latest PBS Scorecard
The scientist behind a breakthrough in antibiotics has said Australia does
'embarrassingly little drug discovery/development R&D for the immense pool of
highly talented scientists we have'
Calls to ban codeine-containing products are an over-reaction to addiction
problems, health care professionals should just do a better job says PSA
president, Grant Kardachi
Evidence from an expert witness described as a 'gun for hire' that was shown to
be inconsistent with something he said in another case over 10 years ago
played a significant role the recent Yasmin patent suit lawyers say
Standard clinical trial costs should apply equally to both commercial and non-
commercial sponsors of clinical trials, says the Pharmaceutical Industry Council,
comprising Medicines Australia, GMiA and Ausbiotech.
A battle over children's painkillers has hit the Federal Court, with Reckitt
Benckiser Healthcare defending its turf on children's Nurofen against
GlaxoSmithKline's Children's Panadol
The flurry of proposals for radical PBS reform that took place in the months leading up to last week's 2013-14 Budget was ignored by the government, meaning it's back to the drawing board for proponents of NZ-style pricing for Australia
» full report
